|
|
Prepublished online as a Blood First Edition Paper on May 22, 2003; DOI 10.1182/blood-2002-12-3634.

Submitted December 3, 2002
Accepted May 10, 2003
Induction of pro-angiogenic signaling by a synthetic peptide derived from the 2nd intracellular loop of S1P3(EDG3)
Tamar Licht, Lilia Tsirulnikov, Hadas Reuveni, Talia Yarnitzky, and Shmuel A Ben-Sasson*
Keryx Biopharmaceuticals, Jerusalem, Israel
Department of Experimental Medicine and Cancer Research, The Hebrew University - Hadassah Medical School, Jerusalem, Israel
* Corresponding author; email: muli{at}md.huji.ac.il.
The G-protein coupled receptors of the endothelial differentiation gene (EDG) family mediate pro-angiogenic activities, such as endothelial cell proliferation, chemotaxis, and vessel morphogenesis. We synthesized and tested the effects of a nine-amino acid peptide (KRX-725), derived from the second intracellular loop of S1P3 (EDG3). KRX-725 mimics the effects of sphingosine 1-phosphate (S1P), the natural ligand of S1P3, by triggering a Gi-dependent MEK-ERK signal transduction pathway. Utilizing aortic rings as an ex-vivo model of angiogenesis, vascular sprouting was assessed in the presence of KRX-725 or S1P. KRX-725 induced extensive and dense vascular sprouts, which contain an elaborated organization of endothelial and smooth muscle layers, including lumen formation. When KRX-725 or S1P were combined with pro-angiogenic factors like basic fibroblast growth factor (bFGF), stem cell factor or vascular endothelial growth factor, the effect was synergistic, leading to further enhancement of vascular sprouting. KRX-725 also initiated neovascularization in a mouse corneal pocket assay in vivo and showed synergism with bFGF. The specificity of KRX-725 was demonstrated via peptide-induced receptor internalization of S1P3 but not S1P1. The ability of a short peptide to stimulate extensive angiogenesis and to synergize with pro-angiogenic factors, suggest that KRX-725 may serve as a useful agent in treating pathologic conditions such as peripheral vascular disease, cardiac ischemia or tissue grafts.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
N. Song, Y. Huang, H. Shi, S. Yuan, Y. Ding, X. Song, Y. Fu, and Y. Luo
Overexpression of Platelet-Derived Growth Factor-BB Increases Tumor Pericyte Content via Stromal-Derived Factor-1{alpha}/CXCR4 Axis
Cancer Res.,
August 1, 2009;
69(15):
6057 - 6064.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. K. Means and J. H. Brown
Sphingosine-1-phosphate receptor signalling in the heart
Cardiovasc Res,
May 1, 2009;
82(2):
193 - 200.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sakao, L. Taraseviciene-Stewart, C. D. Cool, Y. Tada, Y. Kasahara, K. Kurosu, N. Tanabe, Y. Takiguchi, K. Tatsumi, T. Kuriyama, et al.
VEGF-R blockade causes endothelial cell apoptosis, expansion of surviving CD34+ precursor cells and transdifferentiation to smooth muscle-like and neuronal-like cells
FASEB J,
November 1, 2007;
21(13):
3640 - 3652.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Bonnaud, C. Niaudet, G. Pottier, M.-H. Gaugler, J. Millour, J. Barbet, L. Sabatier, and F. Paris
Sphingosine-1-Phosphate Protects Proliferating Endothelial Cells from Ceramide-Induced Apoptosis but not from DNA Damage-Induced Mitotic Death
Cancer Res.,
February 15, 2007;
67(4):
1803 - 1811.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. H. Walter, U. Rochwalsky, J. Reinhold, F. Seeger, A. Aicher, C. Urbich, I. Spyridopoulos, J. Chun, V. Brinkmann, P. Keul, et al.
Sphingosine-1-Phosphate Stimulates the Functional Capacity of Progenitor Cells by Activation of the CXCR4-Dependent Signaling Pathway via the S1P3 Receptor
Arterioscler Thromb Vasc Biol,
February 1, 2007;
27(2):
275 - 282.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Kaidanovich-Beilin and H. Eldar-Finkelman
Peptides Targeting Protein Kinases: Strategies and Implications.
Physiology,
December 1, 2006;
21(6):
411 - 418.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Y. Niv, H. Rubin, J. Cohen, L. Tsirulnikov, T. Licht, A. Peretzman-Shemer, E. Cna'an, A. Tartakovsky, I. Stein, S. Albeck, et al.
Sequence-based Design of Kinase Inhibitors Applicable for Therapeutics and Target Identification
J. Biol. Chem.,
January 9, 2004;
279(2):
1242 - 1255.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|